Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Heterologous Expression of Cyp2k1 and Identification of the Expressed Protein (bv-Cyp2k1) As Lauric Acid (ω-1)-Hydroxylase and Aflatoxin B1exo-Epoxidase

Yea-Huey Yang, Cristobal L. Miranda, Marilyn C. Henderson, Jun-Lan Wang-Buhler and Donald R. Buhler
Drug Metabolism and Disposition November 2000, 28 (11) 1279-1283;
Yea-Huey Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristobal L. Miranda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn C. Henderson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun-Lan Wang-Buhler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald R. Buhler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

LMC2 is the most abundant constitutively expressed hepatic cytochrome P450 found in sexually immature rainbow trout (Onchorynchus mykiss) and is also the isozyme that activates the carcinogen aflatoxin B1 (AFB1). This P450 has been cloned, sequenced, and designated as CYP2K1. The present report describes the heterologous expression of enzymatically active CYP2K1 (BV-CYP2K1) in baculovirus Spodoptera frugiperda (Sf9) insect cells and its catalytic and immunoreactivity characterization in comparison with that of the previously purified LMC2 P450. Homogenates of Sf9 cells expressing the CYP2K1 enzyme and LMC2 both catalyzed the hydroxylation of lauric acid and the epoxidation of AFB1 in the presence of rat NADPH-cytochrome P450 reductase. Both LMC2 and BV-CYP2K1 catalyzed the oxidation of lauric acid primarily at the (ω-1) position plus small amounts at the (ω-2) position. Formation of AFB1 epoxide was shown indirectly by the appearance of an AFB1 epoxide-glutathione conjugate when P450 incubation mixtures contained AFB1, glutathione (GSH) together with mouse liver cytosol or purified rat GSH-transferase. When the AFB1 epoxide-GSH conjugate produced by BV-CYP2K1 and purified LMC2 was analyzed by HPLC using a chiral column, it had a retention time identical to that produced by CYP3A4, a human P450 known to form exclusively the AFB1 exo-epoxide. These results, therefore, confirm that the cDNA-expressed CYP2K1 protein is catalytically and immunologically identical to purified trout LMC2 and that these two enzymes produce primarily the highly carcinogenic stereoisomeric exo-epoxide form of AFB1.

Footnotes

  • Send reprint requests to: Dr. Donald R. Buhler, Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis OR 97331-7301. E-mail:Donald.Buhler{at}orst.edu

  • This work was supported by National Institute on Environmental Health Sciences Grants ES00210, ES03850, and ES04766.

  • Abbreviations used are::
    CYP
    cytochrome P450
    AFB1
    aflatoxin B1
    LA
    lauric acid
    AcMNPV
    Autographa californica nuclear polyhedrosis virus
    GST
    glutathioneS-transferase
    PCR
    polymerase chain reaction
    BV-CYP2K1
    recombinant trout CYP2K1 produced in baculovirus-infected insect cells
    DLPC
    dilaurylphosphatidylcholine
    GC/MS
    gas chromatography/mass spectrometry
    GSH
    glutathione
    • Received April 13, 2000.
    • Accepted August 10, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (11)
Drug Metabolism and Disposition
Vol. 28, Issue 11
1 Nov 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Heterologous Expression of Cyp2k1 and Identification of the Expressed Protein (bv-Cyp2k1) As Lauric Acid (ω-1)-Hydroxylase and Aflatoxin B1exo-Epoxidase
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Heterologous Expression of Cyp2k1 and Identification of the Expressed Protein (bv-Cyp2k1) As Lauric Acid (ω-1)-Hydroxylase and Aflatoxin B1exo-Epoxidase

Yea-Huey Yang, Cristobal L. Miranda, Marilyn C. Henderson, Jun-Lan Wang-Buhler and Donald R. Buhler
Drug Metabolism and Disposition November 1, 2000, 28 (11) 1279-1283;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Heterologous Expression of Cyp2k1 and Identification of the Expressed Protein (bv-Cyp2k1) As Lauric Acid (ω-1)-Hydroxylase and Aflatoxin B1exo-Epoxidase

Yea-Huey Yang, Cristobal L. Miranda, Marilyn C. Henderson, Jun-Lan Wang-Buhler and Donald R. Buhler
Drug Metabolism and Disposition November 1, 2000, 28 (11) 1279-1283;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics